knowledge -WSS

knowledge

author：focus 2025-09-03 18:45:14 - browse：9927

The Food and Drug Administration on Friday approved the world’s first medicine based on CRISPR gene-editing technology, a groundbreaking treatment for sickle cell disease that delivers a potential cure for people born with the chronic and life-shortening blood disorder.

The new medicine, called Casgevy, is made by Vertex Pharmaceuticals and CRISPR Therapeutics. Its authorization is a scientific triumph for the technology that can efficiently and precisely repair DNA mutations — ushering in a new era of genetic medicines for inherited diseases.

In a clinical trial, Casgevy was shown to eliminate recurrent episodes of debilitating pain caused by sickle cell, which afflicts approximately 100,000 people in the U.S., a vast majority of whom are Black. The therapy, whose scientific name is exa-cel, is described as a potential cure because the genetic fix enabled by CRISPR is designed to last a lifetime, although confirmation will require years of follow-up.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： How one medical school became remarkably diverse
Next article： Medicare eyes cuts to doctors, raises to outpatient clinics in 2024

leisure time

entertainment

WSS

Congress: Eradicate hepatitis C and reduce the deficit

RFK Jr. accused of antisemitic claims about COVID but insists he was misunderstood

How to make over

Trans patients at the end of life deserve respect and dignity

Mike Pence clashes with Tucker Carlson in Iowa

Study: Spinal cord stimulation helps patients with paralysis walk again

entertainment

knowledge

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

California store owner shot dead in dispute over displaying Pride flag: Police

Guidelines to prevent youth baseball injuries need more muscle

Trans patients at the end of life deserve respect and dignity

Duchenne breakthrough therapy leaves behind pioneering families

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Roche's accidental data boosts hopes for anti

Medicare proposal to cover medical devices draws a mixed reaction

Global childhood vaccinations edge closer to pre

hotspot

National associations that represent hospice owe an apology

CDC says it’s too soon to assess risk posed by Covid subvariant

Roche's accidental data boosts hopes for anti

Wegovy improves function in certain heart failure patients

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

leisure time

knowledge

entertainment

entertainment